title: Use of randomly amplified polymorphic DNA markers (RAPD) to demonstrate nosocomial contamination in a case of lethal invasive aspergillosis.
authors.forename: A
authors.initials: A
authors.lastname: Paugam
authors.forename: M E
authors.initials: ME
authors.lastname: Bougnoux
authors.forename: F
authors.initials: F
authors.lastname: Robert
authors.forename: J
authors.initials: J
authors.lastname: Dupouy-Camet
authors.forename: L
authors.initials: L
authors.lastname: Fierobe
authors.forename: J F
authors.initials: JF
authors.lastname: Dhainaut
authors.forename: H
authors.initials: H
authors.lastname: Girardin
mesh_terms: D000328:Adult; D001228:Aspergillosis / Q000175:diagnosis*; D001232:Aspergillus fumigatus; D001249:Asthma / Q000150:complications; D001992:Bronchoalveolar Lavage Fluid; D003428:Cross Infection / Q000175:diagnosis*; D004271:DNA, Fungal / Q000032:analysis; D005260:Female; D005819:Genetic Markers / Q000235:genetics*; D006801:Humans; D011110:Polymorphism, Genetic; D012128:Respiratory Distress Syndrome / Q000150:complications
chemical_list: D004271:DNA, Fungal; D005819:Genetic Markers